'Pulse On America' Show to Feature Global Pharmatech
2007年1月11日 - 10:30PM
PRニュース・ワイアー (英語)
Thursday, January 11, 2007 8:30 ET JILIN, China, Jan. 11
/Xinhua-PRNewswire/ -- Global Pharmatech, Inc. (OTC Bulletin Board:
GBLP; the 'Company') a company that develops, manufactures and
markets proprietary botanical drugs and dietary supplements,
announced that it will be featured in Platinum Television Group's
television series, Pulse On America*. The 5 minute long segment
will be aired on CNN Headline News through the cable providers in
many major U.S. cities. The first airing is on Thursday, January
11, in Detroit, MI. The detailed airing schedule for January 2007
is as follows, with more airing times to follow: CNN Headline News
Detroit Comcast Thurs. 1/11 @ 10:24 AM Thurs. 1/11 @ 11:24 AM Fri.
1/12 @ 8:24 AM Fri. 1/12 @ 10:24 AM Fri. 1/12 @ 1:24 PM Sat. 1/13 @
10:24 AM Sat. 1/13 @ 11:24 AM CNN Headline News Chicago, IL Comcast
Cable Sat. 1/13 @ 8:24 PM Sun. 1/14 @ 10:24 AM Sun. 1/14 @ 1:24 PM
Sun. 1/14 @ 5:24 PM Sun. 1/14 @ 8:24 PM Mon. 1/15 @ 10:24 AM Mon.
1/15 @ 1:24 PM CNN Headline News Sarasota-Venice, FL Comcast Cable
Segment 14: Global Pharmatech Sun. 1/21 @ 3:54 PM Sun. 1/21 @ 5:54
PM Sat. 1/27 @ 7:54 AM Sat. 1/27 @ 8:54 AM Sat. 1/27 @ 9:54 AM Sat.
1/27 @ 10:54 AM Sat. 1/27 @ 12:54 PM The Company is currently
looking for regional distributors for two of its products featured
in the show. For more information on the products or distribution
of its products, please visit http://www.global-pharmatech.com/ . *
Pulse on America has no direct affiliation with CNN Headline News.
About Global Pharmatech Global Pharmatech, through its
subsidiaries, develops, manufactures and markets proprietary drugs
that are based on Traditional Chinese Medicine using modern
facilities and advanced R&D technologies. The company offers a
full range of start-to-finish biotech services, from research and
testing to manufacture and sale of liquid and solid dose products.
The Company employs unique proprietary extraction methods and also
licenses patents and technologies for botanical/biological drug
products. Global Pharmatech's operations are currently based in the
People's Republic of China with sales distribution centers in
China, Malaysia, Singapore and Indonesia. For more information,
please visit http://www.global-pharmatech.com/ . About Platinum
Television Group Platinum Television Group, founded in 1997, is an
independent media production company that specializes in
educational programming for national and international markets.
Since its inception, PTG producers have helped companies from
around the world gain exposure via nationwide broadcast television,
cable and satellite distributions systems. For over eight years,
PTG has produced magazine-style shows, nationally and
internationally televised specials as well as a variety of
corporate communications. PTG shows provide information on the
latest in cutting edge technology, travel, sports, fashion,
business solutions, health and a mix of many other exciting topics.
Over the years, PTG's diverse programs have brought forth stories
on a variety of companies including Emerson, Burlington, Reebok,
Trane, ECR, Honeywell, Mooney, Tyndale House, Hirsch Industries,
Optifast/Novartis, Whirlpool, Mag Instrument, Bible League,
Citigroup, PECO, DaySpring, Civil Air Patrol, Jim Beam, Casio,
Motorola, Hormel, just to name a few. PTG's multi-cultural,
multi-talented producers combine decades of experience with
cutting-edge technology. Setting industry standards in quality
educational programming, PTG's talented staff of over 70 full-time
employees produce hundreds of hours of programming each month,
reaching viewers around the world. Safe Harbor Statement under the
Private Securities Litigation Reform Act of 1995 This news release
contains forward-looking statements within the meaning of the 'safe
harbour' provisions of the Private Securities Litigation Reform Act
of 1995. These statements are based upon our current expectations
and speak only as of the date hereof. Our actual results may differ
materially and adversely from those expressed in any
forward-looking statements as a result of various factors and
uncertainties, including our ability to successfully develop and
commercialize products, competitive products in our key markets,
changes in consumer demand for our products, legislative,
regulatory and competitive developments and general economic
conditions. Our SEC filings discuss some of the important risk
factors that may affect our business, results of operations and
financial condition. We undertake no obligation to revise or update
publicly any forward-looking statements for any reason. For more
information, please contact: Zhuojun Li Investor Relations Global
Pharmatech, Inc. Tel: +1-905-787-8225 Email: DATASOURCE: Global
Pharmatech, Inc. CONTACT: Zhuojun Li, Investor Relations of Global
Pharmatech, Inc., +1-905-787-8225, or Web Site:
http://www.global-pharmatech.com/
Copyright